Skip to main content
Premium Trial:

Request an Annual Quote

C-Path Opens Rockville Office to Be Close to Biotech Belt, Federal Gov't

NEW YORK (GenomeWeb News) — The Critical Path Institute has opened an office in Rockville, Md., the Tucson, Ariz.-based non-profit said this week.
 
C-Path moved into the offices in January, but made an official announcement on Monday.  
 
C-Path was formed to support the US Food and Drug Administration, pharmaceutical companies, and academic institutions as the FDA tries to implement its Critical Path Initiative to accelerate the drug-development process.
 
C-Path Chief Scientific Officer Jeff Cossman told GenomeWeb Daily News today that it is important that C-Path have a presence near the FDA, the National Institutes of Health, the numerous biotech companies in the region, and the US Congress.
 
Cossman, who was former medical director of Gene Logic, said that “because the NIH is so under-funded these days” C-Path is working directly with Capitol Hill on legislation to help acquire extra federal funding for drug-development programs.
 
Cossman also said that being near many industry scientists makes it easier to recruit them to help pursue the aims of the Critical Path Initiative and to share scientific information.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.